Lymphatic involvement, including chylous effusion (5.517% vs. 14.4% vs. 25.42%) and retroperitoneal LAM (12.41% vs. 17.80% vs. 42.99%) was strongly associated with higher VEGF-D levels (P < 0.0001 for both). This evidence concerns the gene VEGFD and lymphangioleiomyomatosis.